Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,055 SEK | +2,75 % | +17,16 % | +15,97 % |
Resumen de negocios
Número de empleados: 11
Ventas por actividad
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Non-invasive Blood Tests
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +35,66 % |
Ventas por región
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Sweden
59,1
%
| 1 | 59,2 % | 1 | 59,1 % | +35,40 % |
United States
40,9
%
| 0 | 0,0 % | 0 | 40,9 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 01/04/22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 01/03/23 |
Chief Tech/Sci/R&D Officer | - | 01/02/23 | |
Linda Mellby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas C. King
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 71 | 01/01/13 | |
Philipp Mathieu
BRD | Director/Board Member | 46 | 20/01/22 |
Tobias Bülow
IRC | Investor Relations Contact | - | 15/01/22 |
Cindy Callahan
SAM | Sales & Marketing | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 70 | 09/12/16 | |
Peter Andersen
CHM | Chairman | 67 | 01/01/20 |
Michael Löfman
BRD | Director/Board Member | - | 22/05/23 |
Martin Møller
BRD | Director/Board Member | 49 | 01/01/21 |
Eric Krafft
BRD | Director/Board Member | 49 | 01/04/22 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 20/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 45 287 498 | 34 200 305 ( 75,52 %) | 0 | 75,52 % |
Información de la empresa
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,97 % | 8,49 M | |
-12,91 % | 19,08 mil M | |
-46,21 % | 2651,07 M | |
+18,15 % | 1869,51 M | |
-3,12 % | 1613,82 M | |
+23,78 % | 1207,7 M | |
-10,69 % | 1024,71 M | |
-20,89 % | 905 M | |
-18,10 % | 682 M | |
-7,14 % | 716 M |
- Bolsa de valores
- Acciones
- Acción IMMNOV
- Empresa Immunovia AB